At 14 months, tests revealed that Blake had a moderate form of spinal muscular atrophy. As she got older, the muscle loss caused her bones to weaken, and she suffered fractures. She could no longer sit up in the bathtub, and had trouble swallowing food. In May of 2015, when she was 4, Blake was accepted into a clinical trial for Spinraza, also known as nusinersen. 